Pituitary

, 11:171 | Cite as

Male hypogonadism

  • Andrea M. Isidori
  • Elisa Giannetta
  • Andrea Lenzi
Article

Abstract

The hypothalamic–pituitary–gonadal (HPG) axis regulates the development, endocrine and reproductive function of the gonads throughout all phases of life. Male hypogonadism is defined an inadequate gonadal function, as manifested by deficiency in gametogenesis and/or secretion of gonadal hormones. In most cases, male hypogonadism is diagnosed through detailed history, physical examination and a few basic hormonal evaluations. In selected cases, however, additional tests are needed to define the aetiology and the extent of HPG axis dysfunction. These include semen analysis, pituitary imaging studies, genetic studies, bone densitometry, testicular ultrasonography, testicular biopsy and hormonal dynamic testing. The stimulation tests of the HPG are of particular importance in the differential diagnosis of congenital delayed puberty versus pre-pubertal hypogonadism in children. This review will focus on the methods, indications and limitations of endocrine testing in the characterisation and differential diagnosis of male hypogonadism at various ages. A practical hands-on guide on how to perform these tests is also provided.

Keywords

Puberty Testicular failure Kallman Cryptorchidism Infertility Klinefelter 

References

  1. 1.
    Atwood CS, Meethal SV, Liu T et al (2005) Dysregulation of the hypothalamic–pituitary–gonadal axis with menopause and andropause promotes neurodegenerative senescence. J Neuropathol Exp Neurol 64:93–103PubMedGoogle Scholar
  2. 2.
    Vadakkadath MS, Atwood CS (2005) The role of hypothalamic–pituitary–gonadal hormones in the normal structure and functioning of the brain. Cell Mol Life Sci 62:257–270. Medline. doi: 10.1007/s00018-004-4381-3 CrossRefGoogle Scholar
  3. 3.
    American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update. Endocr Pract 8:440–456Google Scholar
  4. 4.
    Atwood CS, Smith MA, Bowen RL (2005) Feedback on a feedback loop: the hypothalamic–pituitary–gonadal axis. J Alzheimers Dis 7:1–2PubMedGoogle Scholar
  5. 5.
    Braden TD, Conn PM (1992) Activin-A stimulates the synthesis of gonadotropin-releasing hormone receptors. Endocrinology 130:2101–2105. Medline. doi: 10.1210/en.130.4.2101 PubMedCrossRefGoogle Scholar
  6. 6.
    de Winter JP, Vanderstichele HM, Timmerman MA, Blok LJ, Themmen AP, de Jong FH (1993) Activin is produced by rat Sertoli cells in vitro and can act as an autocrine regulator of Sertoli cell function. Endocrinology 132:975–982. Medline. doi: 10.1210/en.132.3.975 PubMedCrossRefGoogle Scholar
  7. 7.
    de Winter JP, Vanderstichele HM, Verhoeven G, Timmerman MA, Wesseling JG, de Jong FH (1994) Peritubular myoid cells from immature rat testes secrete activin-A and express activin receptor type II in vitro. Endocrinology 135:759–767. Medline. doi: 10.1210/en.135.2.759 PubMedCrossRefGoogle Scholar
  8. 8.
    Lee W, Mason AJ, Schwall R, Szonyi E, Mather JP (1989) Secretion of activin by interstitial cells in the testis. Science 243:396–398. Medline. doi: 10.1126/science.2492117 PubMedCrossRefGoogle Scholar
  9. 9.
    de Kretser DM, Buzzard JJ, Okuma Y et al (2004) The role of activin, follistatin and inhibin in testicular physiology. Mol Cell Endocrinol 225:57–64. Medline. doi: 10.1016/j.mce.2004.07.008 PubMedCrossRefGoogle Scholar
  10. 10.
    Bilezikjian LM, Turnbull AV, Corrigan AZ, Blount AL, Rivier CL, Vale WW (1998) Interleukin-1beta regulates pituitary follistatin and inhibin/activin betaB mRNA levels and attenuates FSH secretion in response to activin-A. Endocrinology 139:3361–3364. Medline. doi: 10.1210/en.139.7.3361 PubMedCrossRefGoogle Scholar
  11. 11.
    Finkelstein JS, Badger TM, O’Dea LS, Spratt DI, Crowley WF (1988) Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. J Clin Invest 81:1725–1733PubMedCrossRefGoogle Scholar
  12. 12.
    Thomas GB, Brooks AN (1997) Pituitary and gonadal responses to the long-term pulsatile administration of gonadotrophin-releasing hormone in fetal sheep. J Endocrinol 153:385–391. Medline. doi: 10.1677/joe.0.1530385 PubMedCrossRefGoogle Scholar
  13. 13.
    Spratt DI, Crowley WF Jr (1988) Pituitary and gonadal responsiveness is enhanced during GnRH-induced puberty. Am J Physiol 254:E652–E657PubMedGoogle Scholar
  14. 14.
    Finkelstein JS, Spratt DI, O’Dea LS et al (1989) Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men. J Clin Endocrinol Metab 69:377–385PubMedGoogle Scholar
  15. 15.
    Cortes D, Muller J, Skakkebaek NE (1987) Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl 10:589–596PubMedCrossRefGoogle Scholar
  16. 16.
    Radicioni AF, Anzuini A, De Marco E, Nofroni I, Castracane VD, Lenzi A (2005) Changes in serum inhibin B during normal male puberty. Eur J Endocrinol 152:403–409. Medline. doi: 10.1530/eje.1.01855 PubMedCrossRefGoogle Scholar
  17. 17.
    Rosenfield RL (1990) Clinical review 6: diagnosis and management of delayed puberty. J Clin Endocrinol Metab 70:559–562PubMedGoogle Scholar
  18. 18.
    Weiss J, Crowley WF Jr, Jameson JL (1989) Normal structure of the gonadotropin-releasing hormone (GnRH) gene in patients with GnRH deficiency and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69:299–303PubMedGoogle Scholar
  19. 19.
    Green JS, Parfrey PS, Harnett JD et al (1989) The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 321:1002–1009PubMedGoogle Scholar
  20. 20.
    Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL (1996) Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest 98:1055–1062PubMedCrossRefGoogle Scholar
  21. 21.
    Holm VA, Cassidy SB, Butler MG et al (1993) Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91:398–402PubMedGoogle Scholar
  22. 22.
    Crowley WF Jr, Jameson JL (1992) Clinical counterpoint: gonadotropin-releasing hormone deficiency: perspectives from clinical investigation. Endocr Rev 13:635–640. Medline. doi: 10.1210/er.13.4.635 PubMedCrossRefGoogle Scholar
  23. 23.
    Degros V, Cortet-Rudelli C, Soudan B, Dewailly D (2003) The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty. Eur J Endocrinol 149:23–29. Medline. doi: 10.1530/eje.0.1490023 PubMedCrossRefGoogle Scholar
  24. 24.
    Forest MG (1985) Sexual maturation of the hypothalamus: pathophysiological aspects and clinical implications. Acta Neurochir (Wien) 75:23–42. Medline. doi: 10.1007/BF01406321 CrossRefGoogle Scholar
  25. 25.
    Wu FC, Brown DC, Butler GE, Stirling HF, Kelnar CJ (1993) Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys. J Clin Endocrinol Metab 76:26–31. Medline. doi: 10.1210/jc.76.1.26 PubMedCrossRefGoogle Scholar
  26. 26.
    Besser GM, McNeilly AS, Anderson DC et al (1972) Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. BMJ 3:267–271PubMedGoogle Scholar
  27. 27.
    Marshall JC, Harsoulis P, Anderson DC, McNeilly AS, Besser GM, Hall R (1972) Isolated pituitary gonadotrophin deficiency: gonadotrophin secretion after synthetic luteinizing hormone and follicle stimulation hormone-releasing hormone. BMJ 4:643–645PubMedGoogle Scholar
  28. 28.
    Mortimer CH, Besser GM, McNeilly AS et al (1973) Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic–pituitary–gonadal dysfunction. BMJ 4:73–77PubMedGoogle Scholar
  29. 29.
    Smals AG, Hermus AR, Boers GH, Pieters GF, Benraad TJ, Kloppenborg PW (1994) Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypogonadotropic hypogonadism. J Clin Endocrinol Metab 78:602–608. Medline. doi: 10.1210/jc.78.3.602 PubMedCrossRefGoogle Scholar
  30. 30.
    Wilson DA, Hofman PL, Miles HL, Unwin KE, McGrail CE, Cutfield WS (2006) Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty. J Pediatr 148:89–94. Medline. doi: 10.1016/j.jpeds.2005.08.045 PubMedCrossRefGoogle Scholar
  31. 31.
    Zamboni G, Antoniazzi F, Tato L (1995) Use of the gonadotropin-releasing hormone agonist triptorelin in the diagnosis of delayed puberty in boys. J Pediatr 126:756–758. Medline. doi: 10.1016/S0022–3476(95)70406-X PubMedCrossRefGoogle Scholar
  32. 32.
    Lanes R, Gunczler P, Osuna JA et al (1997) Effectiveness and limitations of the use of the gonadotropin-releasing hormone agonist leuprolide acetate in the diagnosis of delayed puberty in males. Horm Res 48:1–4PubMedGoogle Scholar
  33. 33.
    Ghai K, Cara JF, Rosenfield RL (1995) Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys—a clinical research center study. J Clin Endocrinol Metab 80:2980–2986. Medline. doi: 10.1210/jc.80.10.2980 PubMedCrossRefGoogle Scholar
  34. 34.
    Barron JL, Millar RP, Searle D (1982) Metabolic clearance and plasma half-disappearance time of D-TRP6 and exogenous luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 54:1169–1173PubMedGoogle Scholar
  35. 35.
    Ehrmann DA, Rosenfield RL, Cuttler L, Burstein S, Cara JF, Levitsky LL (1989) A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies. J Clin Endocrinol Metab 69:963–967PubMedGoogle Scholar
  36. 36.
    Ibanez L, Potau N, Zampolli M et al (1994) Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab 78:30–35. Medline. doi: 10.1210/jc.78.1.30 PubMedCrossRefGoogle Scholar
  37. 37.
    Partsch CJ, Hermanussen M, Sippell WG (1985) Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone. J Clin Endocrinol Metab 60:1196–1203PubMedGoogle Scholar
  38. 38.
    Kauschansky A, Dickerman Z, Phillip M, Weintrob N, Strich D (2002) Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys. Clin Endocrinol (Oxf) 56:603–607. Medline. doi: 10.1046/j.1365–2265.2002.01520.x CrossRefGoogle Scholar
  39. 39.
    Delemarre-van de Waal HA (2004) Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism—diagnostic and therapeutic aspects. Eur J Endocrinol 151(Suppl 3):U89–U94. Medline. doi: 10.1530/eje.0.151U089 PubMedCrossRefGoogle Scholar
  40. 40.
    Gordon D, Cohen HN, Beastall GH, Perry B, Thomson JA (1988) Hormonal responses in pubertal males to pulsatile gonadotropin releasing hormone (GnRH) administration. J Endocrinol Invest 11:77–83PubMedGoogle Scholar
  41. 41.
    Bickel A, Dickstein G (1989) Factors predicting the outcome of varicocele repair for subfertility: the value of the luteinizing hormone-releasing hormone test. J Urol 142:1230–1234PubMedGoogle Scholar
  42. 42.
    Marks JL, McMahon R, Lipshultz LI (1986) Predictive parameters of successful varicocele repair. J Urol 136:609–612PubMedGoogle Scholar
  43. 43.
    Okuyama A, Namiki M, Koide T et al (1981) Pituitary and gonadal function in prepubertal and pubertal boys with hypospadias. Acta Endocrinol (Copenh) 98:464–469Google Scholar
  44. 44.
    Schiff I, Wilson E, Newton R et al (1976) Serum luteinizing hormone, follicle-stimulating hormone, and testosterone responses to gonadotropin-releasing factor in males with varicoceles. Fertil Steril 27:1059–1061PubMedGoogle Scholar
  45. 45.
    Segenreich E, Israilov S, Shmuele J, Niv E, Baniel J, Livne P (1998) Evaluation of the relationship between semen parameters, pregnancy rate of wives of infertile men with varicocele, and gonadotropin-releasing hormone test before and after varicocelectomy. Urology 52:853–857. Medline. doi: 10.1016/S0090-4295(98)00336-7 PubMedCrossRefGoogle Scholar
  46. 46.
    Santen RJ, Leonard JM, Sherins RJ, Gandy HM, Paulsen CA (1971) Short- and long-term effects of clomiphene citrate on the pituitary-testicular axis. J Clin Endocrinol Metab 33:970–979PubMedGoogle Scholar
  47. 47.
    Forest MG (1983) How should we perform the human chorionic gonadotrophin (hCG) stimulation test? Int J Androl 6:1–4PubMedCrossRefGoogle Scholar
  48. 48.
    Dunkel L, Perheentupa J, Sorva R (1985) Single versus repeated dose human chorionic gonadotropin stimulation in the differential diagnosis of hypogonadotropic hypogonadism. J Clin Endocrinol Metab 60:333–337PubMedCrossRefGoogle Scholar
  49. 49.
    Dunkel L, Perheentupa J, Apter D (1985) Kinetics of the steroidogenic response to single versus repeated doses of human chorionic gonadotropin in boys in prepuberty and early puberty. Pediatr Res 19:1–4. Medline. doi: 10.1203/00006450-198501000-00001 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Andrea M. Isidori
    • 1
  • Elisa Giannetta
    • 1
  • Andrea Lenzi
    • 1
  1. 1.Department of Medical Pathophysiology (DFM-Fisiopatologia Medica)‘Sapienza’ University of RomeRomeItaly

Personalised recommendations